Colchicine for cardiovascular prevention: the dawn of a new era has finally come

A Bonaventura, A Abbate - 2023 - academic.oup.com
The US Food and Drug Administration (FDA) has recently approved colchicine to reduce the
risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular (CV) …
被引用次数：10 相关文章

[引用][C] Colchicine for cardiovascular prevention: the dawn of a new era has finally come

A Bonaventura, A Abbate - ascvd-lipidology.knowledgehub …
Case Study: A 40-year old female presents with elevated cholesterol. She is asymptomatic,
premenopausal, nondiabetic, does not smoke and has a normal blood pressure. Her father …

[引用][C] Colchicine for cardiovascular prevention: the dawn of a new era has finally come

A Bonaventura, A Abbate - European heart journal, 2023 - pubmed.ncbi.nlm.nih.gov
Colchicine for cardiovascular prevention: the dawn of a new era has finally come Colchicine
for cardiovascular prevention: the dawn of a new era has finally come Eur Heart J. 2023 …

Colchicine for cardiovascular prevention: the dawn of a new era has finally come

A Bonaventura, A Abbate - 2023 - academic.oup.com
The US Food and Drug Administration (FDA) has recently approved colchicine to reduce the
risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular (CV) …

[引用][C] Colchicine for cardiovascular prevention: the dawn of a new era has finally come.

A Bonaventura, A Abbate - European Heart Journal, 2023 - europepmc.org
Colchicine for cardiovascular prevention: the dawn of a new era has finally come. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …